Abstract
Human T-cell leukemia virus type 1 (HTLV-1) causes adult T-cell leukemia-lymphoma (ATL) and inflammatory diseases. To enhance cell-to-cell transmission of HTLV-1, the virus increases the number of infected cells in vivo. HTLV-1 bZIP factor (HBZ) is constitutively expressed in HTLV-1 infected cells and ATL cells and promotes T-cell proliferation. However, the detailed mechanism by which it does so remains unknown. Here, we show that HBZ enhances the proliferation of expressing T cells after stimulation via the T-cell receptor. HBZ promotes this proliferation by influencing the expression and function of multiple co-inhibitory receptors. HBZ suppresses the expression of BTLA and LAIR-1 in HBZ expressing T cells and ATL cells. Expression of T cell immunoglobulin and ITIM domain (TIGIT) and Programmed cell death 1 (PD-1) was enhanced, but their suppressive effect on T-cell proliferation was functionally impaired. HBZ inhibits the co-localization of SHP-2 and PD-1 in T cells, thereby leading to impaired inhibition of T-cell proliferation and suppressed dephosphorylation of ZAP-70 and CD3ζ. HBZ does this by interacting with THEMIS, which associates with Grb2 and SHP-2. Thus, HBZ interacts with the SHP containing complex, impedes the suppressive signal from PD-1 and TIGIT, and enhances the proliferation of T cells. Although HBZ was present in both the nucleus and the cytoplasm of T cells, HBZ was localized largely in the nucleus by suppressed expression of THEMIS by shRNA. This indicates that THEMIS is responsible for cytoplasmic localization of HBZ in T cells. Since THEMIS is expressed only in T-lineage cells, HBZ mediated inhibition of the suppressive effects of co-inhibitory receptors accounts for how HTLV-1 induces proliferation only of T cells in vivo. This study reveals that HBZ targets co-inhibitory receptors to cause the proliferation of infected cells.
MeSH terms
-
Animals
-
Basic-Leucine Zipper Transcription Factors / genetics
-
Basic-Leucine Zipper Transcription Factors / metabolism*
-
CD3 Complex / metabolism
-
Cell Line, Tumor
-
Cell Proliferation / physiology*
-
Encephalomyelitis, Autoimmune, Experimental / virology
-
GRB2 Adaptor Protein / metabolism
-
HTLV-I Infections / transmission*
-
HTLV-I Infections / virology
-
Human T-lymphotropic virus 1 / pathogenicity*
-
Humans
-
Intercellular Signaling Peptides and Proteins
-
Jurkat Cells
-
Lymphocyte Activation / immunology
-
Mice
-
Mice, Inbred C57BL
-
Mice, Transgenic
-
Programmed Cell Death 1 Receptor / biosynthesis
-
Programmed Cell Death 1 Receptor / metabolism
-
Protein Tyrosine Phosphatase, Non-Receptor Type 11 / metabolism
-
Proteins / metabolism*
-
Receptors, Immunologic / biosynthesis
-
Receptors, Immunologic / metabolism
-
Retroviridae Proteins / genetics
-
Retroviridae Proteins / metabolism*
-
T-Lymphocytes / immunology*
-
ZAP-70 Protein-Tyrosine Kinase / metabolism
Substances
-
BTLA protein, mouse
-
Basic-Leucine Zipper Transcription Factors
-
CD3 Complex
-
CD3 antigen, zeta chain
-
GRB2 Adaptor Protein
-
Grb2 protein, mouse
-
HBZ protein, human T-cell leukemia virus type I
-
Intercellular Signaling Peptides and Proteins
-
Pdcd1 protein, mouse
-
Programmed Cell Death 1 Receptor
-
Proteins
-
Receptors, Immunologic
-
Retroviridae Proteins
-
T cell Ig and ITIM domain protein, mouse
-
leukocyte-associated immunoglobulin-like receptor 1
-
themis protein, mouse
-
ZAP-70 Protein-Tyrosine Kinase
-
Zap70 protein, mouse
-
Protein Tyrosine Phosphatase, Non-Receptor Type 11
-
Ptpn11 protein, mouse
Grants and funding
This research is supported by the Project for Cancer Research And Therapeutic Evolution (P-CREATE) from Japan Agency for Medical Research and development, AMED, and by JSPS KAKENHI Grant Numbers JP16H05336 (MM), JP26460554 (JY) and JP16J08048 (HK), and a grant from Mitsubishi Foundation (MM). This study was also supported in part by the JSPS Core-to-Core Program A, Advanced Research Networks. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.